Haemophilia: Vol 14, No 1

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Haemophilia

Journal list menu

Tools

Follow journal

Haemophilia: Volume 14, Issue 1

Download PDFs

Editorial

Haemophilia: January 2008

Review Articles

Staunch protections: the ethics of haemophilia gene transfer research

Review of quality of life: menorrhagia in women with or without inherited bleeding disorders

Chemical synoviorthesis with oxytetracycline clorhydrate (Emicine®) in recurrent haemarthrosis

Original Articles

Clinical haemophilia

Physicians’ perceptions of adherence to prophylactic clotting factor infusions

Tissue plasminogen activator to prevent central venous access device infections: a systematic review of central venous access catheter thrombosis, infection and thromboprophylaxis

Factor VIII inhibitor bypassing activity (FEIBA) – addressing safety issues

Inhibitors

Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor

Immune tolerance therapy utilizing factor VIII/von Willebrand factor concentrate in haemophilia A patients with high titre factor VIII inhibitors

Correction(s) for this article

Corrigendum

Erratum

Obstetrics

Pregnancy in carriers of haemophilia

Paediatrics

The impact on parents of developments in the care of children with bleeding disorders

Laboratory investigation

Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B

Tyr346→Cys mutation results in factor VIII:C assay discrepancy and a normal bleeding phenotype – is this mild haemophilia A?

Orthopaedics

The impact of haemophilia on the success of total hip arthroplasty

Trapezoid supracondylar femoral extension osteotomy for knee flexion contractures in patients with haemophilia

Rare bleeding disorders

Seven novel point mutations in the F11 gene in Iranian FXI-deficient patients

Molecular characterization of five Italian families with inherited severe factor XIII deficiency

Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram

Commentaries

Debate

Best practice: protecting research subjects, patients and experimental animals

Experimental animal use in the study of haemophilic bleeding

Protecting the joints of mice and men

The impact of joint bleeding and synovitis on physical ability and joint function in a murine model of haemophilic synovitis

Consensus guideline

Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group

Correction(s) for this article

Erratum

Meeting Report

Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report

Letters to the Editors

Increased risk of bleeding with the use of tipranavir boosted with ritonavir in haemophilic patients

Factor VIII products and inhibitor development: concepts for revision of European regulatory guidelines

Sonography for assessment of knee arthropathy in Brazilian haemophilic patients

Efficacy of rituximab treatment in postpartum acquired haemophilia A

Gastrointestinal bleeding due to angiodysplasia in patients with type 1 von Willebrand disease: report on association and management

Central venous catheter-related thrombosis after replacement therapy for intracranial bleeding in a patient with afibrinogenaemia

Clinical pictures and prevalence of factor VII deficiency in Northeastern of Iran

Successful use of recombinant factor VIIa in a patient with paraneoplastic factor XI inhibitor

Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy

A novel mutation of α2-plasmin inhibitor gene causes an inherited deficiency and a bleeding tendency

Sign up for email alerts

Tools

More from this journal

Chemical synoviorthesis with oxytetracycline clorhydrate (Emicine^®) in recurrent haemarthrosis